drugset / Trial / NCT07585396
Inositol in Letrozol Resistant PCOS Women
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Polycystic ovary syndrome (PCOS),is a complex neuro-endocrine disorder affecting approximately 5% to 10% of women in reproductive age.Inositols are considered insulin sensitizers, as they modulate the members of insulin signaling pathways.Thiss study compares between the effect of inositol and metformin in letrozol resistant PCOS women.
Timeline
- Start
- 2025-05-10
- Primary completion
- 2026-05-10
- Completion
- 2026-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | D-chiro-inositol | Small molecule | — | — |
| Comparator | Inositol | Small molecule | — | — |
| Comparator | Metformin | Small molecule | 500 mg | Oral |